These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32759067)

  • 1. Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework.
    Berg AT; Gaebler-Spira D; Wilkening G; Zelko F; Knupp K; Dixon-Salazar T; Villas N; Meskis MA; Harwell V; Thompson T; Sims S; Nesbitt G
    Epilepsy Behav; 2020 Oct; 111():107287. PubMed ID: 32759067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare diseases - rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies.
    Berg AT; Kaat AJ; Zelko F; Wilkening G
    Epilepsy Behav; 2022 Mar; 128():108586. PubMed ID: 35158285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNQ2-DEE: developmental or epileptic encephalopathy?
    Berg AT; Mahida S; Poduri A
    Ann Clin Transl Neurol; 2021 Mar; 8(3):666-676. PubMed ID: 33616268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome.
    Berg AT; Levy SR; Testa FM
    Epilepsia; 2018 Nov; 59(11):2096-2105. PubMed ID: 30255934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
    Poke G; Stanley J; Scheffer IE; Sadleir LG
    Neurology; 2023 Mar; 100(13):e1363-e1375. PubMed ID: 36581463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.
    Beck VC; Isom LL; Berg AT
    J Pediatr; 2021 Oct; 237():41-49.e1. PubMed ID: 34181986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.
    LoPresti M; Igarashi A; Sonohara Y; Bowditch S
    Epilepsy Behav; 2024 May; 154():109741. PubMed ID: 38555725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey.
    Berg AT; Dixon-Salazar T; Meskis MA; Danese SR; Le NMD; Perry MS
    Epilepsy Res; 2024 Feb; 200():107280. PubMed ID: 38183688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies.
    Donnan AM; Schneider AL; Russ-Hall S; Churilov L; Scheffer IE
    Neurology; 2023 Apr; 100(16):e1712-e1722. PubMed ID: 36750385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.
    Aljaafari D; Fasano A; Nascimento FA; Lang AE; Andrade DM
    Epilepsia; 2017 Mar; 58(3):e44-e48. PubMed ID: 28186331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of genetic diagnosis in individuals with developmental and epileptic encephalopathies.
    Luiza Benevides M; de Moraes HT; Granados DMM; Bonadia LC; Sauma L; Augusta Montenegro M; Guerreiro MM; Lopes-Cendes Í; Carolina Coan A
    Epilepsy Behav; 2024 Jun; 155():109762. PubMed ID: 38636144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-advocate-led global coalition adapting fit-for-purpose outcomes measures to assure meaningful inclusion of DEEs in clinical trials.
    Hecker J; Conecker G; Chapman C; Hommer R; Ludwig NN; Sevinc G; Te S; Wojnaroski M; Downs J; Berg AT
    Ther Adv Rare Dis; 2024; 18():26330040241249762. PubMed ID: 38911512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome.
    He N; Li BM; Li ZX; Wang J; Liu XR; Meng H; Tang B; Bian WJ; Shi YW; Liao WP
    J Neurodev Disord; 2018 Mar; 10(1):10. PubMed ID: 29558884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition.
    Pujar S; Cross JH
    Expert Rev Neurother; 2024 Apr; 24(4):383-389. PubMed ID: 38415629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients.
    Juanes M; Loos M; Reyes G; Veneruzzo G; García FM; Aschettino G; Calligaris S; Martín ME; Foncuberta ME; Alonso CN; Caraballo RH
    Medicina (B Aires); 2022; 82(6):856-865. PubMed ID: 36571524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
    Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norwegian population-based study of effectiveness of vagus nerve stimulation in patients with developmental and epileptic encephalopathies.
    Kostov KH; Kostov H; Larsson PG; Henning O; Aaberg KM; Egge A; Peltola J; Lossius MI
    Epilepsia Open; 2024 Apr; 9(2):704-716. PubMed ID: 38318727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nosology of Lennox-Gastaut syndrome].
    Hirt HR
    Nervenarzt; 1996 Feb; 67(2):109-22. PubMed ID: 8851292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results.
    Johannessen Landmark C; Potschka H; Auvin S; Wilmshurst JM; Johannessen SI; Kasteleijn-Nolst Trenité D; Wirrell EC
    Epilepsia; 2021 Apr; 62(4):857-873. PubMed ID: 33638459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.